Leonard Valentino: Deeply Grateful to be Nominated for the 2026 Galien Patient First Award
Leonard Valentino, President of WFH USA, shared The Galien Foundation’s post on LinkedIn:
“I am deeply grateful and humbled to be nominated for the 2026 Galien Patient First Award.
Thank you to the review committee The Galien Foundation for recognizing the work of the Bleeding Disorders Research Collaborative (BDRC) and our commitment to advancing a new model of “patient-led” research.
At the heart of the BDRC is a simple but powerful belief: people living with bleeding disorders should not merely participate in research, they should help lead and inform it as lived experience experts (LEEs). By elevating patient perspectives throughout the research process, we can generate evidence that is more meaningful, relevant, and impactful.
This recognition belongs to the entire community that continues to champion patient-centered innovation.
Learn more about the BDRC.”
The Galien Foundation shared a post on LinkedIn:
2026 Galien Patient First Award Nominees anounced:
Winners will be announced on Oct 29 during the Galien Patient Summit.
Stay updated with Hemostasis Today.
-
Oct 10, 2026, 17:58Archo Farzana Batool: Exploring Medical Writing Through an Article on Iron Deficiency Anemia
-
Oct 10, 2026, 17:53Assessing Frailty in Adults With Hemophilia – JTH
-
Oct 10, 2026, 17:52Fatma Sadeghi: Reducing Maternal Health Inequalities Through Nursing Advocacy
-
Oct 10, 2026, 17:50Grzegorz Hensler: How Apheresis Transformed Blood Cell Separation and Collection
-
Oct 10, 2026, 17:47Hemant K Sharma: Japan’s Universal Artificial Blood Research – A Potential Breakthrough in Transfusion Medicine
-
Oct 10, 2026, 17:40John Strouse: Learning About Bleeding Disorders and Sickle Cell Disease at FWGBD
-
Oct 10, 2026, 17:34Mae Caime: Speaking at the Annual Women’s Retreat for the Hemophilia Community in Florida
-
Oct 10, 2026, 17:30Chokri Ben Lamine: PNH beyond the Textbook Triad
-
Oct 10, 2026, 17:29Ruah Alyamany: Thrombosis and Anticoagulation in Hematological Malignancies at SOHO KSA 2026